Evaluating novel antimicrobials within EU joint clinical assessments

Angus Macfarlane, George Bray, Matthias Hofer and Grace Hampson

Contract Research from Office of Health Economics

Abstract: Antimicrobial resistance (AMR) is a growing global health and economic threat. It is responsible for an additional 9.5 million hospital days and costs across the European Union (EU) and European Economic Area (EEA) economies €11.7 billion annually.

JEL-codes: I1 (search for similar items in EconPapers)
Date: 2026-04-16
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/evaluating-novel- ... linical-assessments/ (text/html)
https://www.ohe.org/wp-content/uploads/2026/04/Mac ... al-assessments-1.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:conres:002529

Access Statistics for this paper

More papers in Contract Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).